Showing 1841-1850 of 3073 results for "".
- Registration Opens for the Tell-All Tribune and Genesis Meetingshttps://modernaesthetics.com/news/register-now-for-the-tell-all-tribune-and-genesis-meetings/2473764/Registration is open for two Modern Aesthetics meetings that were overwhelmingly popular in 2024 and now will be held on the same weekend, June 20-21, at the W Hotel in Fort Lauderdale, Florida.
- Merz Aesthetics Extends Partnership with North Carolina Women’s Teamhttps://modernaesthetics.com/news/merz-aesthetics-extends-partnership-with-north-carolina-womens-team/2473765/Merz Aesthetics announced its continued partnership with the Women’s National Soccer League's North Carolina Courage on Tuesday. “We are proud to continue our partnership with the NC Courage, an organization aligned in our shared values of the importance of confidence and empowerment of w
- 2025 AAD: What’s New and True for Energy-Based Deviceshttps://modernaesthetics.com/news/2025-aad-whats-new-and-true-for-energy-based-devices/2473763/At the 2025 American Academy of Dermatology (AAD) Annual Meeting, Modern Aesthetics sat in on “What’s New and What’s True for Energy-Based Devices (EBDs).” The speakers of this lecture included Suzanne L Kilmer, MD, FAAD; Arielle N.B. Kauvar, MD, FAAD; Merete Haedersdal, MD, PhD, FAAD; Jill S. Wa
- ASDSA Raises Patient Safety Concerns After Study Finds Lack of Physician Oversight in Missouri Med Spashttps://modernaesthetics.com/news/asdsa-raises-patient-safety-concerns-after-study-finds-lack-of-physician-oversight-in-missouri-med-spas/2473761/A study published in a recent issue of Dermatologic Surgery reveals a concerning lack of physician supervision and discrepancies in the level of training among those performing cosmetic medical procedures in Missouri medical spas. The study findings highlight the need for regulatory over
- 2025 AAD: Physosocial Implications of Neuromodulator Injectionshttps://modernaesthetics.com/news/2025-aad-physosocial-implications-of-neuromodulator-injections/2473760/The “Botulinum Toxins: The Latest Updates” session at the 2025 American Academy of Dermatology (AAD) Annual Meeting concluded with Vince Bertucci, MD, FAAD, discussing the topic of “Physosocial Implications of Neuromodulator Injections.” Dr. Bertucci explained the facial feedbac
- 2025 AAD: Drs. Shino Bay Aguilera, Michael Somenek Face Off Over Filler Treatmentshttps://modernaesthetics.com/news/2025-aad-drs-shino-bay-aguilera-michael-somenek-face-off-over-filler-treatments/2473759/A ticketed session at the 2025 American Academy of Dermatology (AAD) Annual Meeting brought together leading experts in the field to debate some of the hottest injectable controversies from an evidence-based perspective, helping attendees choose the most appropriate treatments and achieve natural
- 2025 AAD: Treating Hyperpigmented and Hypertrophic Scars with Microneedling in Skin of Colorhttps://modernaesthetics.com/news/2025-aad-treating-hyperpigmented-and-hypertrophic-scars-with-microneedling-in-skin-of-color/2473758/Robyn Siperstein, MD, FAAD, presented “Use of Microneedling in Skin of Color: Treating Hyperpigmented and Hypertrophic Scars” at the 2025 American Academy of Dermatology Annual Meeting Sunday. “The key to this treatment and how I’ve really changed my anti-aging treatments are two things:
- New Solution to Alleviate Challenges from Denied Insurance Claims Unveiledhttps://modernaesthetics.com/news/new-solution-to-alleviate-challenges-from-denied-insurance-claims-unveiled-1/2473757/A new solution to alleviate the challenges posed by insurance claim denials and make it easier for providers to salvage denied claims and increase their reimbursement was on display at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida, as Nextech previewed the late
- 2025 AAD Meeting: Innovations for Treatment of Burn and Trauma Scarshttps://modernaesthetics.com/news/2025-aad-meeting-innovations-for-treatment-of-burn-and-trauma-scars/2473755/The use of lasers and energy-based device technology to treat different types of scars continues to evolve. Arielle N.B. Kauvar, MD, FAAD; Kristen Marie Kelly, MD, FAAD; Girish S. Munavalli, MD, MHS, FAAD; and Jill Waibel, MD, FAAD, explored the traditional and cutting-edge techniques for correct
- FDA Approves South Korean Neurotoxin for Frown Lineshttps://modernaesthetics.com/news/fda-approves-south-korean-neurotoxin-for-frown-lines/2473751/The US Food and Drug Administration approved the neurotoxin, Letybo (letibotulinumtoxinA-wlbg), to treat moderate-to-severe glabellar lines in adults, Hugel Inc. announced last week. According to a press release, Hugel Inc. plans to accelerate its transition for approved medical use with